FIG1.The expression of MG53/TGF-β1, col-a1 and ZO-1 in nasal
tissues of Control、CRSsNP、CRSwNP
A. Immunohistochemistry (magnification 400X) measured the expression of
Col-a1 and ZO-1 in nasal tissues of Control, CRSsNP and CRSwNP (n=5 per
group). B. Immunofluorescence (magnification 800X) measured the
expression of ZO-1 in nasal tissues of Control, CRSsNP and CRSwNP (n=3
per group ). C. Western blot analysis for MG53/TGF-β1/Smad/ Col-a1 /ZO-1
in nasal tissues of Control, CRSsNP and CRSwNP, and GAPDH expression in
total protein extracted from nasal tissues.D. MG53/TGF-β1/Smad2、3/
Col-a1 /ZO-1 were quantified by densitometric analysis using ImageJ
software, and data were expressed as relative values against GAPDH (n=4
per group). E. The expressions of MG53/TGF-β1/Smad/ Col-a1 /ZO-1 in
nasal tissues of Control, CRSsNP and CRSwNP were analyzed by RT-qPCR
(compared with Control).
Error bars are shown as means ±SEMs. Significance was calculated by
using the paired Student t test. *p<0.05
and**p<0.01.